GASTRIC FIBROSIS

This adverse event was reported 17 times

These drugs are most commonly taken by patients reporting GASTRIC FIBROSIS:

# Drug Count
0 PREDNISONE 5
1 USTEKINUMAB 5
2 ADALIMUMAB 4
3 ADALIMUMAB-AATY 4
4 ADALIMUMAB-ADAZ 4
5 ADALIMUMAB-FKJP 4
6 INFLIXIMAB 4
7 MESALAMINE 4
8 MIRIKIZUMAB-MRKZ 4
9 VEDOLIZUMAB 4
See all common drugs associated with GASTRIC FIBROSIS

GASTRIC FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIRIKIZUMAB-MRKZ 4 0.0044
1 CYSTEAMINE BITARTRATE 1 0.0010
2 OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE 1 0.0008
3 CLOMIPRAMINE HYDROCHLORIDE 1 0.0002
4 AMANTADINE HYDROCHLORIDE 1 0.0002
5 MESALAMINE 4 0.0001
6 ADALIMUMAB-FKJP 4 0.0001
7 ADALIMUMAB-AATY 4 0.0001
8 ADALIMUMAB-ADAZ 4 0.0001
9 PARICALCITOL 1 0.0001
See all drugs enriched for association with GASTRIC FIBROSIS

GASTRIC FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vitamin D2 Analog [EPC] 1 0.0001
1 Vitamin D Analog [EPC] 1 0.0001
2 Interleukin-12 Antagonist [EPC] 5 0.0000
3 Interleukin-23 Antagonist [EPC] 5 0.0000
4 Integrin Receptor Antagonist [EPC] 4 0.0000
5 Aminosalicylate [EPC] 4 0.0000
6 Aldosterone Antagonist [EPC] 1 0.0000
7 Janus Kinase Inhibitor [EPC] 1 0.0000
8 Estrogen [EPC] 1 0.0000
9 Interferon beta [EPC] 1 0.0000
See all drug classes enriched for association with GASTRIC FIBROSIS